What components are measured in a standard lipid panel (lipid profile)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Standard Lipid Panel Components

A standard lipid panel measures five core components: total cholesterol, LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), non-HDL cholesterol (non-HDL-C), and triglycerides 1, 2.

Core Lipid Panel Components

The Canadian Society of Clinical Chemists explicitly recommends that clinical laboratories offer a lipid panel consisting of these five parameters 1, 2:

  • Total cholesterol (TC) - measures all cholesterol in the blood
  • LDL cholesterol (LDL-C) - typically calculated using equations rather than directly measured
  • HDL cholesterol (HDL-C) - the "protective" cholesterol
  • Non-HDL cholesterol (non-HDL-C) - calculated as total cholesterol minus HDL-C, representing total atherogenic burden
  • Triglycerides (TG) - fat molecules in the blood

These five parameters form the foundation for cardiovascular risk assessment and treatment decisions 3.

Additional Tests Available Separately

Lipoprotein(a) [Lp(a)] and Apolipoprotein B (ApoB) should be offered only as individually orderable tests, not as part of the standard panel 1, 2. These are typically requested by specialists (lipidologists, endocrinologists, cardiologists) in specific clinical scenarios:

  • Lp(a) - useful when there is premature vascular disease without obvious risk factors, family history of premature CVD, or suspected familial hypercholesterolemia 1
  • ApoB - superior to LDL-C for therapeutic decision-making but adds analytical cost 4

Important Technical Details

Fasting vs. Non-Fasting

Modern guidelines support non-fasting lipid assessment for routine screening 1, 5. The maximal mean changes after habitual meals are not clinically significant (triglycerides increase by only 0.3 mmol/L or 26 mg/dL) 5. However, fasting assessment is required for diagnosis and pharmacological therapy decisions, using the average of at least 2 fasting profiles obtained 2 weeks to 3 months apart 1.

LDL-C Calculation

LDL-C is calculated rather than directly measured. The newer NIH equation is superior to the traditional Friedewald equation, particularly for non-fasting samples, high triglycerides (up to 9.04 mmol/L), and low LDL-C (down to 0.50 mmol/L) 2.

Non-HDL-C Superiority

Non-HDL-C appears superior to LDL-C for predicting CVD risk because it accounts for the total atherogenic particle burden, including not only LDL-C but also triglyceride-rich lipoproteins and their remnants 1.

Common Pitfall

A significant discordance exists between LDL-C and ApoB concentrations in approximately 24% of patients 6. When LDL-C and ApoB are discordant, ApoB more accurately reflects atherogenic burden and should guide treatment decisions 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.